• Luminex (Austin, Texas) reported three executive appointments, all effective July 1. Michael Pintek has been named senior VP, operations. Pintek joins Luminex from Roche, where he most recently was VP/GM, blood screening. Jeremy Bridge-Cook, PhD, has been named senior VP, assay group. Bridge-Cook has previously served as VP of Luminex Molecular Diagnostics. Nancy Krunic, PhD, has been named VP, Luminex Molecular Diagnostics. Krunic has previously served as associate VP, clinical and regulatory affairs, with Luminex Molecular Diagnostics. Luminex makes biological testing technologies with applications throughout the diagnostic and life sciences industries.

Michael Reitermann has been named the new CEO of Siemens Healthcare's (Malvern, Pennsylvania) U.S. organization. Most recently, Reitermann was CEO of Siemens Molecular Imaging Business Unit. Siemens claims that its Healthcare Sector is one of the world's largest suppliers to the healthcare industry.

Kendall Stever was named CFO of Verathon (Bothell, Washington). Prior to joining Verathon, Stever headed his own consulting business, Double Diamond Consulting. Verathon makes BladderScan bladder volume instruments and GlideScope video laryngoscopes.